{
  "subject": "85e2559f536528522cee64fdf9fe09feec5421b8bd1cf1d114d32a517c111db3",
  "claims": [
    {
      "id": "title",
      "proposition": {
        "predicate": "title",
        "object": "Determination That DIBENZYLINE (Phenoxybenzamine Hydrochloride) Oral Capsule, 10 Milligrams, and Other Drug Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness"
      },
      "time": {
        "asserted": "2026-11-18T21:09:36.088Z"
      },
      "force": "quotes",
      "provenance": {
        "witness": "https://www.federalregister.gov",
        "method": "quoted collector metadata from an original HTTP response",
        "citation": "https://www.federalregister.gov/documents/2026/11/13/2026-23141/determination-that-dibenzyline-phenoxybenzamine-hydrochloride-oral-capsule-10-milligrams-and-other",
        "sourceDigest": "sha256:ab52e6b17705928544682b2f3394e229bb69add9d32fdbf099bc1d22673988d4"
      },
      "status": "unverified"
    },
    {
      "id": "summary",
      "proposition": {
        "predicate": "summary",
        "object": "The Food and Drug Administration (FDA or Agency) has determined that the drug products listed in this document were not withdrawn from sale for reasons of safety or effectiveness. This determination means that FDA will not begin procedures to withdraw approval of abbreviated new drug applications (ANDAs) that refer to these drug products, and it will allow FDA to continue to approve ANDAs that refer to the products as long as they meet relevant legal and regulatory requirements."
      },
      "time": {
        "asserted": "2026-11-18T21:09:36.088Z"
      },
      "force": "quotes",
      "provenance": {
        "witness": "https://www.federalregister.gov",
        "method": "quoted collector metadata from an original HTTP response",
        "citation": "https://www.federalregister.gov/documents/2026/11/13/2026-23141/determination-that-dibenzyline-phenoxybenzamine-hydrochloride-oral-capsule-10-milligrams-and-other",
        "sourceDigest": "sha256:ab52e6b17705928544682b2f3394e229bb69add9d32fdbf099bc1d22673988d4"
      },
      "status": "unverified"
    },
    {
      "id": "url",
      "proposition": {
        "predicate": "url",
        "object": "https://www.federalregister.gov/documents/2026/11/13/2026-23141/determination-that-dibenzyline-phenoxybenzamine-hydrochloride-oral-capsule-10-milligrams-and-other"
      },
      "time": {
        "asserted": "2026-11-18T21:09:36.088Z"
      },
      "force": "quotes",
      "provenance": {
        "witness": "https://www.federalregister.gov",
        "method": "quoted collector metadata from an original HTTP response",
        "citation": "https://www.federalregister.gov/documents/2026/11/13/2026-23141/determination-that-dibenzyline-phenoxybenzamine-hydrochloride-oral-capsule-10-milligrams-and-other",
        "sourceDigest": "sha256:ab52e6b17705928544682b2f3394e229bb69add9d32fdbf099bc1d22673988d4"
      },
      "status": "unverified"
    },
    {
      "id": "source-subject",
      "proposition": {
        "predicate": "source-subject",
        "object": "federal-register:2026-23141"
      },
      "time": {
        "asserted": "2026-11-18T21:09:36.088Z"
      },
      "force": "quotes",
      "provenance": {
        "witness": "https://www.federalregister.gov",
        "method": "quoted collector metadata from an original HTTP response",
        "citation": "https://www.federalregister.gov/documents/2026/11/13/2026-23141/determination-that-dibenzyline-phenoxybenzamine-hydrochloride-oral-capsule-10-milligrams-and-other",
        "sourceDigest": "sha256:ab52e6b17705928544682b2f3394e229bb69add9d32fdbf099bc1d22673988d4"
      },
      "status": "unverified"
    },
    {
      "id": "source-edition",
      "proposition": {
        "predicate": "source-edition",
        "object": "ni:///sha-256;Wq_n6tU8XzdYjnP8fr-15nuczBc1rhBT6FkAd6IrDlM"
      },
      "time": {
        "asserted": "2026-11-18T21:09:36.088Z"
      },
      "force": "quotes",
      "provenance": {
        "witness": "https://www.federalregister.gov",
        "method": "quoted collector metadata from an original HTTP response",
        "citation": "https://www.federalregister.gov/documents/2026/11/13/2026-23141/determination-that-dibenzyline-phenoxybenzamine-hydrochloride-oral-capsule-10-milligrams-and-other",
        "sourceDigest": "sha256:ab52e6b17705928544682b2f3394e229bb69add9d32fdbf099bc1d22673988d4"
      },
      "status": "unverified"
    },
    {
      "id": "source-metadata",
      "proposition": {
        "predicate": "source-metadata",
        "object": {
          "subject": "federal-register:2026-23141",
          "revision": "ni:///sha-256;Wq_n6tU8XzdYjnP8fr-15nuczBc1rhBT6FkAd6IrDlM",
          "documentNumber": "2026-23141",
          "documentUrl": "https://www.federalregister.gov/documents/2026/11/13/2026-23141/determination-that-dibenzyline-phenoxybenzamine-hydrochloride-oral-capsule-10-milligrams-and-other",
          "title": "Determination That DIBENZYLINE (Phenoxybenzamine Hydrochloride) Oral Capsule, 10 Milligrams, and Other Drug Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness",
          "documentType": "Notice",
          "publicationDate": "2026-11-13",
          "publicationDatePrecision": "civil-day",
          "agencies": [
            "Food and Drug Administration",
            "Health and Human Services Department"
          ],
          "abstract": "The Food and Drug Administration (FDA or Agency) has determined that the drug products listed in this document were not withdrawn from sale for reasons of safety or effectiveness. This determination means that FDA will not begin procedures to withdraw approval of abbreviated new drug applications (ANDAs) that refer to these drug products, and it will allow FDA to continue to approve ANDAs that refer to the products as long as they meet relevant legal and regulatory requirements.",
          "commentsCloseOn": null,
          "commentDeadlineFieldRequested": true,
          "effectiveOn": null,
          "sourceAction": "Notice.",
          "federalRegisterCitation": "91 FR 73252",
          "docketIds": [
            "Docket No. FDA-2026-N-12541"
          ],
          "regulationIdNumbers": [],
          "cfrReferences": [],
          "correctionOf": null,
          "corrections": [],
          "source": {
            "originalApiUrl": "https://www.federalregister.gov/api/v1/documents.json?conditions%5Bpublication_date%5D%5Bgte%5D=2026-11-11&conditions%5Bpublication_date%5D%5Blte%5D=2026-11-18&per_page=100&page=4&order=newest&fields%5B%5D=document_number&fields%5B%5D=title&fields%5B%5D=type&fields%5B%5D=abstract&fields%5B%5D=html_url&fields%5B%5D=publication_date&fields%5B%5D=agencies&fields%5B%5D=comments_close_on&fields%5B%5D=effective_on&fields%5B%5D=action&fields%5B%5D=citation&fields%5B%5D=regulation_id_numbers&fields%5B%5D=cfr_references&fields%5B%5D=docket_ids&fields%5B%5D=correction_of&fields%5B%5D=corrections",
            "originalResponseDigest": "sha256:ab52e6b17705928544682b2f3394e229bb69add9d32fdbf099bc1d22673988d4",
            "originalResponseUri": "ni:///sha-256;q1LmsXcFkoVEaCsvM5TiKbtprdnTL9vwmbwdImc5iNQ",
            "normalizedLotDigest": "sha256:45952d4e6e1e6d60254c4b417ce7a47027218948b609d1a125f3ffd81c9e4baf",
            "observedAt": "2026-11-18T21:09:36.088Z",
            "provider": "https://www.federalregister.gov",
            "publisher": {
              "name": "Office of the Federal Register",
              "source": "https://www.federalregister.gov/reader-aids/developer-resources/rest-api",
              "reproduction": "https://www.archives.gov/federal-register/faqs",
              "officialNotice": "The source Federal Register edition, not this derived JSON, is authoritative. No government endorsement."
            },
            "evidenceClass": "source-dated government metadata, independently replayable from original HTTP bytes held by the source acquisition run"
          }
        }
      },
      "time": {
        "asserted": "2026-11-18T21:09:36.088Z"
      },
      "force": "quotes",
      "provenance": {
        "witness": "https://www.federalregister.gov",
        "method": "quoted collector metadata from an original HTTP response",
        "citation": "https://www.federalregister.gov/documents/2026/11/13/2026-23141/determination-that-dibenzyline-phenoxybenzamine-hydrochloride-oral-capsule-10-milligrams-and-other",
        "sourceDigest": "sha256:ab52e6b17705928544682b2f3394e229bb69add9d32fdbf099bc1d22673988d4"
      },
      "status": "unverified"
    },
    {
      "id": "editorial-standing",
      "proposition": {
        "predicate": "editorial-standing",
        "object": "source metadata; editorial acceptance pending"
      },
      "time": {
        "asserted": "2026-11-18T21:09:36.088Z"
      },
      "force": "quotes",
      "provenance": {
        "witness": "https://www.federalregister.gov",
        "method": "quoted collector metadata from an original HTTP response",
        "citation": "https://www.federalregister.gov/documents/2026/11/13/2026-23141/determination-that-dibenzyline-phenoxybenzamine-hydrochloride-oral-capsule-10-milligrams-and-other",
        "sourceDigest": "sha256:ab52e6b17705928544682b2f3394e229bb69add9d32fdbf099bc1d22673988d4"
      },
      "status": "unverified"
    }
  ]
}
